Also trades as: JSPR (NASDAQ) · $vol 1M
JSPRW NASDAQ
Jasper Therapeutics, Inc.
1W: -96.0%
1M: -98.3%
3M: -98.5%
YTD: -99.7%
1Y: -99.9%
3Y: -99.7%
$0.00
-0.00 (-84.62%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$84M
-10.0% ▼
Net Income
$0
+100.0% ▲
EPS (Diluted)
$-3.95
+19.2% ▲
EBITDA
-$84M
-12.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $25M | $35M | $52M | $56M | $63M |
| SG&A Expenses | $11M | $17M | $17M | $20M | $21M |
| Operating Expenses | $37M | $51M | $69M | $76M | $84M |
| Operating Income | -$37M | -$51M | -$69M | -$76M | -$84M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$31M | -$38M | -$64M | -$71M | $0 |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$31M | -$38M | -$64M | -$71M | $0 |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-26.89 | $-10.33 | $-6.18 | $-4.89 | $-3.95 |
| EBITDA | -$36M | -$50M | -$68M | -$75M | -$84M |
| Shares Outstanding | 1M | 4M | 10M | 15M | 15M |